New COVID-19 drug trial seeks faster recovery

NCT ID NCT07157007

Summary

This study is testing whether a new drug called ratutrelvir, when given alongside standard COVID-19 treatment, is safe and helps people recover faster from mild to moderate COVID-19. The trial will enroll 90 adults who have had COVID-19 symptoms for less than 5 days and don't require hospitalization. Researchers will compare how quickly symptoms improve and monitor for any side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chang Gung Memorial Hospital, Linkou Branch

    NOT_YET_RECRUITING

    Taoyuan District, Taoyuan, 333, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Chonnam National University Hospital

    NOT_YET_RECRUITING

    Gwangju, Donggu, 61469, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hallym University Sacred Heart Hospital Gangnam

    NOT_YET_RECRUITING

    Seoul, Seoul, 07441, South Korea

    Contact Email: •••••@•••••

  • Inha University Hospital

    NOT_YET_RECRUITING

    Incheon, Jung-gu, 22332, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kaohsiung Medical University Hospital

    NOT_YET_RECRUITING

    Kaohsiung City, Kaohsiung, 807, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Key Health

    RECRUITING

    Sydney, New South Wales, 2000, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Momentum Clinical Research Taringa

    RECRUITING

    Brisbane, Queensland, 4068, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Novatrial

    RECRUITING

    Charlestown, New South Wales, 2290, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Paratus Clinical(Clinical Trials Institute, Torquay)

    NOT_YET_RECRUITING

    Torquay, Victoria, 3228, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Research Institute of Virology

    RECRUITING

    Tashkent, Tashkent, 100194, Uzbekistan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Taichung Veterans General Hospital

    NOT_YET_RECRUITING

    Taichung, Taichung, 407, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Taipei Medical University Hospital

    NOT_YET_RECRUITING

    Taipei, Taipei, 110, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Taoyuan General Hospital

    NOT_YET_RECRUITING

    Taoyuan District, Taoyuan, 33004, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Catholic University of Korea, Eunpyeong St. Mary's Hospital

    NOT_YET_RECRUITING

    Seoul, Eunpyeong-gu, 07441, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Wonju Severance Christian Hospital

    NOT_YET_RECRUITING

    Wŏnju, Gangwon-do, 26426, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.